Equities

Lyka Labs Ltd

LYKALABS:NSI

Lyka Labs Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)149.02
  • Today's Change2.02 / 1.37%
  • Shares traded100.27k
  • 1 Year change+34.25%
  • Beta1.4076
Data delayed at least 15 minutes, as of Sep 20 2024 11:02 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
REVENUE AND GROSS PROFIT
Total revenue1,1129311,941
OPERATING EXPENSES
Cost of revenue total497376530
Selling, general and admin. expenses, total445186181
Depreciation/amortization128141173
Unusual expense(income)4.117465
Other operating expenses, total13201219
Total operating expense1,0879781,168
Operating income25(47)773
Other, net(44)(81)(179)
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes(9.34)(132)592
Provision for income taxes17(0.19)208
Net income after taxes(26)(132)384
Minority interest1.31(0.59)5.57
Net income before extra. Items(25)(132)390
Total extraordinary items------
Net income(25)(132)390
Inc.avail. to common excl. extra. Items(25)(132)390
Inc.avail. to common incl. extra. Items(25)(132)390
EPS RECONCILIATION
Basic/primary weighted average shares332929
Basic/primary eps excl. extra items(0.75)(4.59)14
Basic/primary eps incl. extra items(0.75)(4.59)14
Dilution adjustment------
Diluted weighted average shares332929
Diluted eps excl. extra items(0.75)(4.59)14
Diluted eps incl. extra items(0.75)(4.59)14
COMMON STOCK DIVIDENDS
DPS - common stock primary issue------
Gross dividend - common stock0----
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental2.563.651.17
SUPPLEMENTAL INCOME
Depreciation, supplemental385456
Total special items4.327465
NORMALISED INCOME
Normalized income before taxes(5.02)(58)658
Effect of special items on income taxes1.442623
Income tax excluding impact of special items1826231
Normalized income after tax(23)(83)427
Normalized income avail. to common(22)(84)432
Basic normalized EPS(0.67)(2.92)15
Diluted normalized EPS(0.67)(2.92)15
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.